The experience of combining agents, specially triptans and non steroidal anti-inflammatory drugs, for the acute treatment of migraine - A Review

Recent Patents on CNS Drug Discovery

Volumn 2, Issue 2, 2007, Pages 141-144

  Krymchantowski, Abouch V ^a,b,d   Jevoux, Carla da C ^c  

^a Headache Center of Rio   (Brazil)

^b Instituto de Neurologia Deolindo Couto   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^d NONE   (Brazil)

Author keywords

Acute treatment; Combination; Migraine; Naproxen; Sumatriptan

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; DOPAMINE RECEPTOR BLOCKING AGENT; ERGOT DERIVATIVE; KETOROLAC; LYSINE ACETYLSALICYLATE; METOCLOPRAMIDE; NAPROXEN; NAPROXEN PLUS SUMATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RIZATRIPTAN; ROFECOXIB; SUMATRIPTAN; TOLFENAMIC ACID; TRIMEBUTINE MALEATE; TRIPTAN DERIVATIVE;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG ABSORPTION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; MEDLINE; MIGRAINE; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; SHORT COURSE THERAPY; UNSPECIFIED SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRYPTAMINES;

EID: 34250698417     PISSN: 15748898     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488907780832733     Document Type: Review

References (49)

1. Stewart WF, Schechter A, Lipton RB. Migraine heterogeneity, disability, pain intensity and attack frequency and duration. Neurology 1994; 44(suppl 4): S24-S39.
2. Rasmussen BK. Epidemiology of headache. Cephalalgia 1995; 15: 45-68.
3. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. 2nd Edition. Cephalalgia 2004; 24(suppl 1): 1-160.
4. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia 1996; 16:231-238.
5. Lipton RB, Stewart WF. Prevalence and impact of migraine. Neurol Clin 1997; 15: 1-13.
6. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - Current understanding and treatment. N Engl J Med 2002; 346: 257-270.
7. Tfelt-Hansen P, Welch KMA. General principles of pharmacological treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The Headaches. 2nd Edition. Philadelphia (PA): Lippincott Willians & Wilkins, 2000: 385-89.
8. Dodick DW. Acute and prophylactic management of migraine. Clin Cornerstone, 2001; 4: 36-52.
9. Tfelt-Hansen P, Lipton RB. Prioritizing treatmeat. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press; 1993: 359-362.
10. Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002; 42(suppl 1): 3-9.
11. Peroutka SJ. Beyond Monotherapy: Rational polytherapy in migraine. Headache 1998; 38: 18-22.
12. Diener HC, Limmroth V. Advances in pharmacological treatment of migraine. Expert Opin Investig Drugs 2001; 10: 1831-1845.
13. Tfelt-Hansen P, De Vries P, Saxena P. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 2000; 60: 1259-1287.
14. Dodick DW. Triptan Nonresponder Studies: implications for clinical practice. Headache 2005; 45: 156-162.
15. Peroutka, SJ. The drug treatment of migraine. In: Hardman JG, Limberd LE, Molinoff PB, Ruddon RW, Giman AG. (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. London: Pergamon; 1996487-502.
16. Lipton RB, Stewart WF, Ryan RE, Saper J, Silberstein SD, Sheftell F. Efficacy and safety of nonprescription combination of acetaminophen, aspirin and caffeine in alleviating headache pain of an acute migraine attack: three double-blind, randomized, placebo-controlled trials. Arch Neurol 1998; 55: 210-217.
17. Dahlof C, Bjorkman R. Diclofenac-K (50 and 100mg) and placebo in the acute treatment of migraine. Cephalalgia 1993; 13: 117-123.
18. Nestvold K, Kloster R, Partinen M, Sulkava R. treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia 1985; 5: 115-119.
19. Kloster R, Nestvold K, Vilming S. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia 1992; 12: 169-171.
20. Sierralta F. Clonixinato de lisina: interacciones com el sistema serotoninérgico y naloxona. Proc 9th Latinoamerican Congress of Pharmacology and Therapeutics, Santiago; 1982: 64. Abstract.
21. Paredes H, Solis R, Palacios J. The use of intravenous lysine clonixinate for rapid pain relief: an open clinical study. Curr Therap Res 1996; 40: 86-91.
22. Orti E. Site-specific effects of the nonsteroidal anti-inflammatory drug lysine clonixinate on rat brain opioid receptors. Pharmacology 1999; 58: 190-9.
23. Kaube H, Hoskin KL, Goadsby PJ. Acetylsalicilic acid inhibits cerebral cortical vasodilatation caused by superior sagittal sinus stimulation in the cat. Eur J Neurol 1994; 1: 141-46.
24. Bates D, Ashford E, Dawson R, et al. Subcutaneous sumatriptan during the migraine aura. Neurology 1994; 44: 1587-1592.
25. Visser WH, de Vriend RH, Jaspers NHWM, Ferrari MD. Sumatriptan - nonresponders: a survey in 366 migraine patients. Headache 1996; 36: 471-475.
26. Dahlof CG. How does sumatriptan perform in clinical practice? Cephalalgia 1995; 15(suppl 15): 21-28.
27. Visser WH, de Vriend RH, Jaspers NHWM, Ferraria MD. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology 1996; 47: 46-51.
28. Krymchantowski AV, Adriano M, Fernandes D. Tolfenamic acid decreases migraine recurrence when used with sumatriptan. Cephalalgia 1999; 19(3): 186-87.
29. Krymchantowski AV. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr 2000; 59(2-B): 428-30.
30. Plachetka, J.R., Chohan, Z.T.: US20067030162 (2006).
31. Lance JW. Headache. Ann Neurol 1981; 10: 1-10.
32. Wilkinson M. treatment of the acute migraine attack - current status. Cephalalgia 1983; 3: 61-67.
33. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A Study to Compare Oral Oral Sumatriptan with Oral Aspirin plus Metoclopramide in the Acute Treatment of Migraine. Eur Neurol 1992; 32: 177-184.
34. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined and lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995; 346: 923-926.
35. Turkel, C.C., Brin, M.F.: WO06078588 (2006).
36. Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander J. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 2005; 45: 983-991.
37. Brandes J, O'Carroll PC, Mannix L, Lener SE, Littlefield D, Alexander WJ. Therapeutic clinical benefits of a new single-tablet formulation of sumatriptan formulated with RT technology and naproxen sodium. Cephalalgia 2005; 25: 860. Abstract.
38. Plachetka, J.R., Kothapalli, V.M., Gilbert, D.L.: US2004180089 (2004).
39. Krymchantowski AV, Barbosa JS. Rizatriptan combined with rofecoxib vs. rizatriptan for the soft treatment of migraine: an open label pilot study. Cephalalgia 2002; 22: 309-312.
40. Krymchantowski AV, Bigal ME, Moreira PF. Rizatriptan vs. rizatriptan plus rofecoxib vs. rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurology 2004; 28(4): 10.
41. Burstein R, Levy D, Collins B, Jakubowski M. Therapeutic approach to migraine with allodynia. Neurology 2005; 64(suppl 1): A151. Abstract.
42. Krymchantowski AV, Bigal ME, Moreira PF. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. Cephalalgia 2006; 26(7): 871-74.
43. Buzzi MG. Reading data in migraine acute treatment studies: from clinical trials to reviews and meta-analyses. J Headache Pain 2006; 7: 160-164.
44. Sackett DL, Richardson WS, Rosenberg WM, Haynes BR. Evidence-based medicine. How to practice and teach EBM. New York: Churchill Livingstone, 2000: 1-98.
45. Sheftell F, Tepper S. New paradigms in the recognition and acute treatment of migraine. Headache 2002; 42: 58-69.
46. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/ 1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002; 22: 633-658.
47. Plachetka, J.R.: US20056926907 (2005).
48. Krymchantowski, A.V.: PI0503323-3 (2005).
49. Krymchantowski, A.V.: US11/542,656 (2006).